| | |
Reuters 05:03 PM | September 29,2009
GlaxoSmithKline won support for its cervical cancer vaccine from an advisory panel to Japan’s Health Ministry, putting it on track to be the first to offer such a vaccine in the world’s second-biggest drug market
|
|
Radhieka Pandeya 12:02 AM | September 16,2009
The drug will be available in the market only 48 hours after the notification is released
|
|
Paula Bustamante / AFP 10:50 AM | August 26,2009
Experts say Jackson showed classic patterns of a drug abuser who sought out a stronger arsenal of drugs to overcome his body’s heightened tolerance to medication
|
|
Bloomberg 10:59 PM | August 25,2009
Sun is pursuing approval from the US FDA to market two dosage forms of the drug before the patents expire in 2012, according to the complaint filed by Sanofi-Aventis SA
|
|
AP 10:27 AM | July 21,2009
In the second quarter of 2008, 28 health care concerns reported spending at least $1 million lobbying
|
|
PTI 02:39 PM | July 10,2009
In the fiscal year 2006, Glenmark and InvaGen entered into a collaborative agreement for the joint development, filing and marketing of several generic pharmaceutical products for the US market
|
|
C.H. Unnikrishnan 10:54 PM | June 17,2009
Deal only covered its businesses, sales and marketing organization and the name of the company and did not include the company’s factory
|
|
PTI 11:47 AM | June 01,2009
Sun Pharmaceutical chairman Dilip Shanghvi said if we are able to get all the shares of Taro Pharmaceuticals including promoters shares then the total cost would be up to Rs1,000 crore
|
|
PTI 05:33 PM | May 29,2009
Japanese drug maker has narrowed its full-year losses at $2.2 billion on account of changes related to accounting guidelines in Japan
|
|
PTI 11:58 AM | May 28,2009
Its parent firm Novartis AG has raised its open offer price to Rs450 a share for acquiring an additional 39% stake in its Indian subsidiary
|
|
Radhieka Pandeya 01:15 AM | May 15,2009
Investors were spooked by a disclosure that it got a warning letter from US Food and Drug Administration
|
|
Radhieka Pandeya 10:20 PM | May 13,2009
Japanese company will have to strengthen its involvement in the management of the Indian firm, says CEO
|
|
C.H. Unnikrishnan 11:35 PM | May 12,2009
Cipla Medpro SA is currently considering the proposed offer by Adcock Ingram under the auspices of the independent sub-committee of the board, the firm’s spokesperson said
|
|
Reuters 02:00 PM | May 06,2009
Avastin cleared for most aggressive brain cancer; accelerated approval following early studies
FIND MORE ARTICLES ON:
FDA RocheAvastinDrug
|
|
Reuters 02:47 PM | May 05,2009
The Indian drug firm will also receive milestone payments and royalties from AstraZeneca on successful sale of any drug
|
|